Abstract
Esophageal strictures are a problem commonly encountered in gastroenterological practice and can be caused by malignant or benign lesions. Dysphagia is the symptom experienced by all patients, regardless of whether their strictures are caused by malignant or benign lesions. The methods most frequently used for palliation of malignant esophageal strictures are stent placement (particularly in patients with an expected survival of 3 months or less) and brachytherapy (in patients with a life expectancy of more than 3 months). Brachytherapy has been shown to be beneficial in patients with an expected survival of longer than 3 months with regard to (prolonged) dysphagia improvement, complications and quality of life. The mainstay of benign esophageal stricture treatment is dilation. Although dilation usually results in symptomatic relief, recurrent strictures do occur. In order to predict which types of strictures are most likely to recur, it is important to differentiate between esophageal strictures that are simple (i.e. focal, straight strictures with a diameter that allows endoscope passage) and those that are more complex (i.e. long (>2 cm), tortuous strictures with a narrow diameter). These complex strictures are considered refractory when they cannot be dilated to an adequate diameter. Novel treatment modalities for refractory strictures include temporary stent placement and incisional therapy.
Key Points
-
Esophageal strictures are a problem frequently encountered by the gastroenterologist and can be subdivided into those with a malignant origin and those with a benign origin
-
The method most frequently used to treat dysphagia caused by esophageal cancer is stent placement, with brachytherapy increasingly being performed, particularly in patients with an expected survival of longer than 3 months
-
Ultraflex™ stents, Flamingo Wallstents and Niti-S stents can all be used for the palliation of dysphagia caused by esophageal cancer, whereas Z-stents and Polyflex® stents seem less preferable because of a higher risk of complications
-
No clear difference in effectiveness has been reported for the Savary-Gilliard® and through-the-scope balloon dilators for the treatment of benign esophageal strictures
-
Stents can be used in patients with complex strictures if these are refractory to dilation therapy
-
Incisional therapy can be a safe alternative treatment modality in patients with firm fibrotic benign strictures, such as can be found at an anastomotic site
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Siersema PD (2006) New developments in palliative therapy. Best Pract Res Clin Gastroenterol 20: 959–978
Lew RJ et al. (2002) A review of endoscopic methods of esophageal dilation. J Clin Gastroenterol 35: 117–126
Steyerberg EW et al. (2005) Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. Gastrointest Endosc 62: 333–340
May A et al. (1996) Self-expanding metal stents for palliation of malignant obstruction in the upper gastrointestinal tract. Comparative assessment of three stent types inplemented in 96 inplantations. J Clin Gastroenterol 22: 261–266
Dorta G et al. (1997) Comparison between esophageal Wallstent and Ultraflex stents in the treatment of malignant stenoses of the esophagus and cardia. Endoscopy 29: 149–154
Schmassmann A et al. (1997) Self-expanding metal stents in malignant esophageal obstruction: a comparison between two stent types. Am J Gastroenterol 92: 400–406
Vakil N et al. (2001) A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 96: 1791–1796
Siersema PD et al. (2001) A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 54: 145–153
Sabharwal T et al. (2003) A randomized prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 52: 922–926
Homs MY et al. (2004) Causes and treatment for recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy 36: 880–886
Verschuur EM et al. (2007) New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol [10.1111/j.1572-0241.2007.01542.x]
Dumonceau JM et al. (1999) Esophageal fistula sealing: choice of stent, practical management, and cost. Gastrointest Endosc 49: 70–78
Verschuur EM et al. (2007) Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest Endosc 66: 1082–1090
Bethge N et al. (1998) Palliation of malignant esophageal obstruction due to intrinsic and extrinsic lesions with expandable metal stents. Am J Gastroenterol 93: 1829–1832
Gupta NK et al. (1999) Self-expanding oesophageal metal stents for the palliation of dysphagia due to extrinsic compression. Eur Radiol 9: 1893–1897
Homs MY et al. (2005) Single-dose brachytherapy for the palliative treatment of esophageal cancer. Endoscopy 37: 1143–1148
Sharma V et al. (2002) Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 52: 310–315
Homs MY et al. (2006) Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer. Brachytherapy 5: 41–48
Homs MY et al. (2004) Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer; multicenter, randomised trial. Lancet 364: 1497–1504
Bergquist H et al. (2005) Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus 18: 131–139
Pereira-Lima JC et al. (1999) Endoscopic dilation of benign esophageal strictures: report on 1043 procedures. Am J Gastroenterol 94: 1497–1501
Poley JW et al. (2004) Ingestion of acid and alkaline agents: outcome and prognostic value of early endoscopy. Gastrointest Endosc 60: 372–377
Honkoop P et al. (1996) Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management. J Thorac Cardiovasc Surg 111: 1141–1148
McClean GK et al. (1989) Shear stress in the performance of esophageal dilation: comparison of balloon dilation and bougienage. Radiology 172: 983–986
Cox JG et al. (1988) Balloon or bougie for dilatation of benign oesophageal strictures? An interim report of a randomized controlled trial. Gut 29: 1741–1747
Yamamoto H et al. (1992) Treatment of benign esophageal strictures by Eden-Puestow or balloon dilators: a comparison between randomized and prospective nonrandomized trials. Mayo Clin Proc 67: 228–236
Saeed ZA et al. (1996) Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus. Gastrointest Endosc 41: 189–195
Scolapio JS et al. (1999) A randomized prospective study comparing rigid to balloon dilators for benign esophageal strictures and rings. Gastrointest Endosc 50: 13–17
Anderson SH et al. (2004) Efficacy and safety of endoscopic dilation of esophageal dilation of esophageal strictures in epidermolysis bullosa. Gastrointest Endosc 59: 28–32
Hernandez LV et al. (2000) Comparison among the perforation rates of Maloney, balloon, and Savary dilation of esophageal strictures. Gastrointest Endosc 51: 460–462
Chiu YC et al. (2004) Factors infuencing clinical applications of endoscopic balloon dilation for benign esophageal strictures. Endoscopy 36: 595–600
Zein NN et al. (1995) Endoscopic intralesional steroid injections in the management of refractory esophageal strictures. Gastrointest Endosc 41: 596–598
Lee M et al. (1995) Preliminary experience with endoscopic intralesional steroid injection therapy for refractory upper gastrointestinal strictures. Gastrointest Endosc 41: 598–601
Kochhar R et al. (1999) Intralesional steroids augment the effects of endoscopic dilation in corrosive esophageal strictures. Gastrointest Endosc 49: 509–513
Ramage Jr JI et al. (2005) A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol 100: 2419–2425
Bueno R et al. (2001) Combined antegrade and retrograde dilation: a new endoscopic technique in the management of complex esophageal obstruction. Gastrointest Endosc 54: 368–372
Lew RJ et al. (2004) Technique of endoscopic retrograde puncture and dilatation of total esophageal stenosis in patients with radiation-induced strictures. Head Neck 26: 179–183
Fiori A et al. (2000) Self-expandable metal coil stents in the treatment of benign esophageal strictures refractory to conventional therapy: a case series. Gastrointest Endosc 52: 259–262
Cwikiel W et al. (1993) Self-expanding metal stent in the treatment of benign esophageal strictures: experimental study and presentation of clinical cases. Radiology 187: 667–671
Evrard S et al. (2004) Self-expanding plastic stents for benign esophageal lesions. Gastrointest Endosc 60: 894–900
Repici A et al. (2004) Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures. Gastrointest Endosc 60: 513–519
Holm AN et al. (2007) Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc [10.1016/j.gie.2007.04.031]
Conio M et al. (2007) A modified self-expanding Niti-S stent for the management of benign hypopharyngeal strictures. Gastrointest Endosc 65: 714–720
Yoon CJ et al. (2004) Removal of retrievable esophageal and gastrointestinal stents: experience in 113 patients. AJR Am J Roentgenol 183: 1437–1444
Johansson J et al. (2000) Anastomotic diameters and strictures following esophagectomy and total gastrectomy in 256 patients. World J Surg 24: 78–84
Schlegel RD et al. (2001) Results of reoperations in colorectal anastomotic strictures. Dis Colon Rectum 44: 1464–1468
Hordijk ML et al. (2006) Electrocautery therapy for refractory anastomotic strictures of the esophagus. Gastrointest Endosc 63: 157–163
Schubert D et al. (2003) Endoscopic treatment of benign gastrointestinal anastomotic strictures using argon plasma coagulation in combination with diathermy. Surg Endosc 17: 1579–1582
Beilstein MC et al. (2005) Endoscopic incision of a refractory esophageal stricture: novel management with an endoscopic scissors. Gastrointest Endosc 61: 623–625
DiSario JA et al. (2002) Incision of recurrent distal esophageal (Schatzki) ring after dilation. Gastrointest Endosc 56: 244–248
Fry SW and Fleischer DE (1997) Management of a refractory benign esophageal stricture with a new biodegradable stent. Gastrointest Endosc 45: 179–182
Sandha GS et al. (1999) Expandable metal stents for benign esophageal obstruction. Gastrointest Endosc Clin N Am 9: 437–446
Won JH et al. (2002) Self-expandable covered metallic esophageal stent impregnated with beta-emitting radionuclide: an experimental study in canine esophagus. Int J Radiat Oncol Biol Phys 53: 1005–1013
Lucktong TA et al. (2002) Resection of benign esophageal stricture through a minimally invasive endoscopic and transgastric approach. Am Surg 68: 720–723
Willingham FF et al. (2007) Taking NOTES: translumenal flexible endoscopy and endoscopic surgery. Curr Opin Gastroenterol 23: 550–555
Acknowledgements
Charles P Vega, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape-accredited continuing medical education activity associated with this article.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Siersema, P. Treatment options for esophageal strictures. Nat Rev Gastroenterol Hepatol 5, 142–152 (2008). https://doi.org/10.1038/ncpgasthep1053
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep1053
This article is cited by
-
CIRSE Standards of Practice on Oesophageal and Gastroduodenal Stenting
CardioVascular and Interventional Radiology (2023)
-
A viewpoint on material and design considerations for oesophageal stents with extended lifetime
Journal of Materials Science (2022)
-
Influences of Stent Design on In-Stent Restenosis and Major Cardiac Outcomes: A Scoping Review and Meta-Analysis
Cardiovascular Engineering and Technology (2022)
-
Endoscopic Management of Refractory Benign Esophageal Strictures
Dysphagia (2021)
-
Factors affecting the outcome of endoscopic dilatation in refractory post-corrosive oesophageal stricture in Egyptian children: a single-centre study
Esophagus (2020)